Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 2009. Start Trial.
Date Value
October 26, 2026 13.78
October 23, 2026 14.09
October 22, 2026 14.14
October 21, 2026 14.62
October 20, 2026 14.86
October 19, 2026 14.21
October 16, 2026 13.62
October 15, 2026 14.72
October 14, 2026 14.21
October 13, 2026 14.50
October 12, 2026 14.56
October 09, 2026 14.62
October 08, 2026 13.31
October 07, 2026 12.92
October 06, 2026 12.96
October 05, 2026 14.15
October 02, 2026 14.22
October 01, 2026 14.23
September 30, 2026 14.82
September 29, 2026 14.45
September 28, 2026 10.99
September 25, 2026 11.00
September 24, 2026 10.80
September 23, 2026 10.19
September 22, 2026 10.64
Date Value
September 21, 2026 10.19
September 18, 2026 10.25
September 17, 2026 10.02
September 16, 2026 9.87
September 15, 2026 9.36
September 14, 2026 9.26
September 11, 2026 8.60
September 10, 2026 8.14
September 09, 2026 8.43
September 08, 2026 8.70
September 04, 2026 8.79
September 03, 2026 8.70
September 02, 2026 8.62
September 01, 2026 8.28
August 31, 2026 8.17
August 28, 2026 8.01
August 27, 2026 8.26
August 26, 2026 8.08
August 25, 2026 8.44
August 24, 2026 8.06
August 21, 2026 8.29
August 20, 2026 8.99
August 19, 2026 7.99
August 18, 2026 7.03
August 17, 2026 7.10

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
AVITA Medical, Inc. 15.18
Halozyme Therapeutics, Inc. 128.01
CareDx, Inc. 69.10
Amgen, Inc. 665.80
Xencor, Inc. 29.18